(Q50313829)

English

Brief report: six months continuation treatment in naltrexone-responsive children with autism: an open-label case-control design.

scientific article published in April 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 March 2018

http://europepmc.org/abstract/MED/10382138

Brief report: six months continuation treatment in naltrexone-responsive children with autism: an open-label case-control design. (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 March 2018

http://europepmc.org/abstract/MED/10382138

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

S H Willemsen-Swinkels

1

1 reference

Europe PubMed Central

PubMed publication ID

2 March 2018

http://europepmc.org/abstract/MED/10382138

J K Buitelaar

2

1 reference

Europe PubMed Central

PubMed publication ID

2 March 2018

http://europepmc.org/abstract/MED/10382138

I A van Berckelaer-Onnes

3

1 reference

Europe PubMed Central

PubMed publication ID

2 March 2018

http://europepmc.org/abstract/MED/10382138

H van Engeland

4

1 reference

Europe PubMed Central

PubMed publication ID

2 March 2018

http://europepmc.org/abstract/MED/10382138

language of work or name

0 references

publication date

1 April 1999

1 reference

Europe PubMed Central

PubMed publication ID

2 March 2018

http://europepmc.org/abstract/MED/10382138

Journal of Autism and Developmental Disorders

1 reference

Europe PubMed Central

PubMed publication ID

2 March 2018

http://europepmc.org/abstract/MED/10382138

29

1 reference

Europe PubMed Central

PubMed publication ID

2 March 2018

http://europepmc.org/abstract/MED/10382138

2

1 reference

Europe PubMed Central

PubMed publication ID

2 March 2018

http://europepmc.org/abstract/MED/10382138

167-169

1 reference

Europe PubMed Central

PubMed publication ID

2 March 2018

http://europepmc.org/abstract/MED/10382138

https://scigraph.springernature.com/pub.10.1023/a:1023000929040

0 references

Naltrexone in young autistic children: replication study and learning measures.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10382138

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison between the handicaps behaviour and skills schedule and the psychoeducational profile.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10382138

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10382138

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The adrenocorticotrophic hormone (4-9) analog ORG 2766 benefits autistic children: report on a second controlled clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10382138

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10382138

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Naltrexone in autistic children: behavioral symptoms and attentional learning

1 reference

https://pubmed.ncbi.nlm.nih.gov/10382138

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factor validity and norms for the aberrant behavior checklist in a community sample of children with mental retardation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10382138

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10382138

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placebo-controlled acute dosage naltrexone study in young autistic children.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10382138

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10382138

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychometric characteristics of the aberrant behavior checklist

1 reference

https://pubmed.ncbi.nlm.nih.gov/10382138

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of methylphenidate in the treatment of children with autistic disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10382138

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clonidine treatment of hyperactive and impulsive children with autistic disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/10382138

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism

1 reference

https://pubmed.ncbi.nlm.nih.gov/10382138

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resolved: autistic children should have a trial of naltrexone.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10382138

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1023000929040

1 reference

Europe PubMed Central

PubMed publication ID

2 March 2018

http://europepmc.org/abstract/MED/10382138

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 March 2018

http://europepmc.org/abstract/MED/10382138

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50313829&oldid=1579503207"